𝔖 Bobbio Scriptorium

✦ LIBER ✦

Anti-HIV agent 1592U89 succinate - progress from synthesis through clinical development: S. M. Daluge, S. W. LaFon, S. S. Good, M. H. St. Clair., D. A. Livingston, M. T. Martin. Glaxo Wellcome, Research Triangle Park, NC, 27709, USA

Book ID: 113259443
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 76 KB
Volume: 30
Category: Article
ISSN: 0166-3542
DOI: 10.1016/0166-3542(96)80227-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1592U89 succinate — a potent, selective

1592U89 succinate — a potent, selective anti-HIV carbocyclic nucleoside: S.M. Daluge, S.S. Good, M.B. Faletto, M.T. Martin, W.H. Miller, D.R. Averett, M.H. St. Clair, L.R. Boone, M. Tisdale1, and J.E. Reardon. Wellcome Research Laboratories, Research Triangle Park, NC 27709, USA, and 1Beckenham, UK

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 79 KB

1592U89 succinate — preclinical toxicolo

1592U89 succinate — preclinical toxicological and disposition studies and preliminary clinical pharmacokinetics: S.S. Good, S.M. Daluge, S.V. Ching, K.M. Ayers, W.B. Mahony, M.B. Faletto, B.A. Domin, B.S. Owens, R.E. Dornsife, J.A. McDowell, S.W. LaFon, and W.T. Symonds. Wellcome Research Laboratories, Research Triangle Park, NC 27709, USA

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 82 KB